Holen Sie sich die Stockscreener-App
4.21
0.24%
0.010
Handel nachbörslich:
4.21
Atara Biotherapeutics Inc Aktie (ATRA) Neueste Nachrichten
Atara Biotherapeutics Provides a Business Update - BioSpace
Atara Biotherapeutics (ATRA) Adjusts Key Financial Agreement - GuruFocus
Atara Biotherapeutics Extends Royalty Milestone, Issues Warrant - TipRanks
Atara Biotherapeutics Defers $9 Million Milestone Payment to 2028, Issues 400,000-Share Warrant to HCR - TradingView
Atara extends $9M milestone payment deadline to 2028 - Investing.com
Atara (NASDAQ: ATRA) extends $9M HCRx payment and grants 400,000-share warrant - Stock Titan
Insider Buy: Is GLBLW showing insider buyingIndex Update & Verified Chart Pattern Signals - baoquankhu1.vn
Aug Spikes: Is Atara Biotherapeutics Inc being accumulated by smart money2025 Buyback Activity & Fast Momentum Entry Tips - baoquankhu1.vn
What is the Moat Score of Atara Biotherapeutics Inc.2025 Sector Review & Technical Pattern Based Buy Signals - mfd.ru
There's No Escaping Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) Muted Revenues - simplywall.st
Exit Recap: Can Atara Biotherapeutics Inc. weather a recessionQuarterly Performance Summary & Weekly Top Stock Performers List - mfd.ru
What are analysts’ price targets for Atara Biotherapeutics Inc.July 2025 WrapUp & Free Expert Approved Momentum Trade Ideas - mfd.ru
Take Profit: Will International Tower Hill Mines Ltd outperform the market in YEARJuly 2025 Short Interest & High Yield Stock Recommendations - baoquankhu1.vn
Is Atara Biotherapeutics Inc. impacted by rising ratesJuly 2025 Highlights & Detailed Earnings Play Alerts - mfd.ru
Will Atara Biotherapeutics Inc. stock recover faster than peersJuly 2025 Price Swings & AI Forecasted Entry/Exit Points - mfd.ru
Is Atara Biotherapeutics Inc. stock ready for breakout2025 Trading Recap & Long-Term Capital Growth Strategies - mfd.ru
Can Atara Biotherapeutics Inc. stock double in the next yearTrend Reversal & Community Consensus Trade Alerts - mfd.ru
How Atara Biotherapeutics Inc. stock trades during market volatility2025 Key Lessons & Stepwise Trade Signal Guides - mfd.ru
How Atara Biotherapeutics Inc. stock reacts to job market dataMarket Trend Report & Technical Pattern Based Signals - mfd.ru
Nasdaq Moves: Will Atara Biotherapeutics Inc benefit from green energy policiesLayoff News & Community Supported Trade Ideas - baoquankhu1.vn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc.ATRA - Chartmill
Highs Report: What analysts say about Atara Biotherapeutics Inc stockMarket Weekly Review & AI Forecast Swing Trade Picks - baoquankhu1.vn
Fundamentals Check: Does Nuveen Churchill Direct Lending Corp have pricing powerJuly 2025 WrapUp & Weekly High Momentum Picks - baoquankhu1.vn
Can Atara Biotherapeutics Inc stock double in the next yearMarket Activity Report & Accurate Intraday Trade Tips - baoquankhu1.vn
Is Atara Biotherapeutics Inc. stock influenced by commodity pricesJuly 2025 Recap & Reliable Breakout Stock Forecasts - mfd.ru
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Atara Biotherapeutics, Inc.ATRA - Chartmill
Once a Ventura County biotech heavyweight, Atara fights for its life - Ventura County Star
Price-Driven Insight from (ATRA) for Rule-Based Strategy - Stock Traders Daily
Short Squeeze: Can Atara Biotherapeutics Inc weather a recessionJuly 2025 WrapUp & Low Drawdown Trading Techniques - baoquankhu1.vn
Dip Buying: Can Marvell Technology Inc withstand a market correctionForecast Cut & Short-Term High Return Ideas - baoquankhu1.vn
Patterns Watch: Can Atara Biotherapeutics Inc weather a recessionMarket Sentiment Summary & Reliable Price Breakout Signals - baoquankhu1.vn
Pancreatic Cancer Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Dragonfly Therapeutics, Keymed B, Tango Therapeutics, Atara Biotherapeutics, Keymed Biosciences Co. Ltd - Barchart.com
Tabelecleucel’s Phase 3 EBV+ PTLD Trial Progress Signals Continued Potential for Atara Biotherapeutics - TipRanks
FinancialContentINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc.ATRA - FinancialContent
What momentum indicators show for Atara Biotherapeutics Inc. stockMarket Rumors and News & Trusted Financial Advisors at No Cost - bollywoodhelpline.com
FDA Again Rejects Atara - labusinessjournal.com
Aug Summary: Will HAFN benefit from green energy policiesStock Surge & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Innovation Ltd Panacea Sells 80,554 Shares of Atara Biotherapeutics (NASDAQ:ATRA) Stock - Defense World
(ATRA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Atara Bio director Huang James sells $489k in shares By Investing.com - Investing.com India
Atara Bio director Huang James sells $489k in shares - Investing.com
Aug Selloffs: Is Atara Biotherapeutics Inc being accumulated by smart moneyTrade Exit Summary & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
FDA Reversal Sends Atara Biotherapeutics into Tailspin: Stock Plummets 67% on Second CRL for Tabelecleucel - FinancialContent
Entry Recap: Is Atara Biotherapeutics Inc stock dividend yield sustainableJuly 2025 Retail & Daily Profit Maximizing Tips - Bộ Nội Vụ
Canaccord Genuity Downgrades Atara Biotherapeutics (ATRA) to Hol - GuruFocus
Atara Biotherapeutics downgraded to Hold from Buy at Canaccord (earlier) - TipRanks
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Atara receives FDA complete response letter for Ebvallo BLA application - Pharmaceutical Business review -
0.20%
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):